The 5 analysts offering 12-month price forecasts for Anavex Life Sciences Corp have a median target of 39.00, with a high estimate of 42.00 and a low estimate of 16.00. The median estimate represents a +295.14% increase from the last price of 9.87.
The current consensus among 6 polled investment analysts is to Buy stock in Anavex Life Sciences Corp. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.15
Reporting Date Aug 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.